ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50 Day Moving Average – Time to Sell?

Posted by ABMN Staff on May 23rd, 2026

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $81.73 and traded as high as $83.21. ProShares Ultra Nasdaq Biotechnology shares last traded at $81.97, with a volume of 6,034 shares trading hands.

ProShares Ultra Nasdaq Biotechnology Stock Performance

The company has a market capitalization of $76.23 million, a PE ratio of 20.68 and a beta of 1.25. The business’s 50-day moving average is $81.73 and its 200-day moving average is $81.64.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Kaizen Financial Strategies raised its holdings in ProShares Ultra Nasdaq Biotechnology by 4.7% in the first quarter. Kaizen Financial Strategies now owns 5,565 shares of the exchange traded fund’s stock worth $483,000 after buying an additional 250 shares during the last quarter. Citadel Advisors LLC purchased a new position in ProShares Ultra Nasdaq Biotechnology in the third quarter worth about $307,000. Palumbo Wealth Management LLC purchased a new position in ProShares Ultra Nasdaq Biotechnology in the third quarter worth about $766,000. Finally, Franklin Resources Inc. purchased a new position in ProShares Ultra Nasdaq Biotechnology in the second quarter worth about $32,000.

ProShares Ultra Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day.